A.R.T. Advisors’s Palisade Bio PALI Stock Holding History

A.R.T. Advisors’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2	Closed	-$19K	–	1616
2019 Q3	$19K	Buy	+2	New	+$27.9K	﹤0.01%	1369
2017 Q4	–	Sell	-1	Closed	-$78K	–	1588
2017 Q3	$78K	Buy	+1	New	+$209K	﹤0.01%	1227
2016 Q2	–	Hold	0	–	-$18K	–	1559
2016 Q1	–	Hold	0	–	–	–	1319

Other funds holding PALI

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

A.R.T. Advisors's PALI Position: Q4 2019 in Review

A.R.T. Advisors sold out of Palisade Bio (PALI) in Q4 2019, closing a stake of 2 shares — an estimated $19K sold.

A.R.T. Advisors first reported a position in PALI in Q3 2017 and held it in 2 quarters. The position peaked at $78K in Q3 2017. 5 funds tracked by Wall St. Rank hold PALI as of Q4 2019.

A.R.T. Advisors reported no remaining Palisade Bio position as of Q4 2019 after selling out during the quarter.
A.R.T. Advisors sold 2 Palisade Bio shares in Q4 2019, an estimated $19K.
A.R.T. Advisors first reported a position in Palisade Bio in Q3 2017 and held it in 2 quarters.
A.R.T. Advisors's Palisade Bio position peaked at $78K in Q3 2017.
5 funds tracked by Wall St. Rank held Palisade Bio as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.